The global human papillomavirus vaccines market size was valued at USD 8.42 billion in 2024 and is projected to reach USD 14.03 billion by 2030, growing at a CAGR of 8.82% from 2025 to 2030. The market’s expansion is largely driven by the rising incidence of HPV-related infections and cancers worldwide, highlighting an urgent need for preventive healthcare measures. HPV...